Prusiner SB, DeArmond SJPrion diseases and neurodegeneration. Annu Rev Neurosci.1994;17:311-339.
6.
Sigurdsson B.Rida, a chronic encephalitis of sheep with general remarks on infections which develop slowly and some of their special characteristics . Br Vet J.1954;110:341-354.
7.
Gajdusek DC, Gibbs CJ, Alpers M.Experimental transmission of a kuru-like syndrome to chimpanzees. Nature. 1966;209:794-796.
8.
Gajdusek DCSlow virus infections of the central nervous system. Am J Clin Pathol.1971;56:320-330.
9.
Gajdusek DCUnconventional viruses and the origin and disappearance of kuru. Science. 1977;197:943-960.
10.
Goldfarb LG , Brown P.The transmissible spongiform encephalopathies . Annu Rev Med.1995;46:57-65.
11.
Prusiner SBGenetic and infectious prion diseases. Arch Neurol.1993;50: 1129-1153.
12.
Merz PA, Rohwer RG, Kascsak R., et al. Infection-specific particle from the unconventional slow virus diseases. Science. 1984;225:437-440.
13.
Bolton DC, McKinley MP, Prusiner SBIdentification of a protein that purifies with the scrapie prion. Science. 1982;218:1309-1311.
14.
Gibbs CJ Jr, Joy A. , Heffner R., et al. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived growth hormone. NEngl J Med.1985;313:734-738.
15.
Diringer H. , Gelderblom H., Hilmert H., et al. Scrapie infectivity, fibrils, and low molecular weight protein. Nature. 1983 ;306:476-478.
16.
Prusiner SBMolecular biology of prion diseases. Science.1991;252: 1515-1522.
17.
Oesch B., Westaway D., Walchli M., et al. A cellular gene encodes scrapie PrP 27-30 protein. Cell. 1985;40:735-746.
18.
Chesebro B., Race R., Wehrly K., et al. Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature. 1985;315:331-333.
19.
Sparkes RS, Simon M., Cohn VH, et al. Assignment of the human and mouse prion protein genes to homologous chromosomes. Proc Natl Acad Sci USA. 1986;83:7358-7362.
20.
Meyer RK, McKinley MP, Bowman KA, et al. Separation and properties of cellular and scrapie prion proteins . Proc Natl Acad Sci USA. 1986;83:2310-2314.
21.
Barry RA, Kent Sbh, McKinley MP, et al. Scrapie and cellular prion proteins share polypeptide epitopes . J Infect Dis. 1986;153:848-854.
22.
Barry RA, Prusiner SBMonoclonal antibodies to the cellular and scrapie prion proteins. J Infect Dis. 1986;154: 518-521.
23.
Hay B., Prusiner SB, Lingappa V.R.Alternative secretory and transmembrane fates for biogenesis of the scrapie prion protein. Biochemistry (in press).
24.
Pan K-M., Baldwin M., Nguyen J., et al. Conversion of alpha helices into beta sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA. 1993;90:10962-10966.
25.
Stahl N., Baldwin MA, Teplow DB, et al. Structural analysis of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry.1993;32:1991-2002.
26.
Prusiner SB , Hsiao KKHuman prion diseases. Ann Neurol.1994;35:385-395.
27.
Prusiner SB , Scott M., Foster D., et al. Transgenic studies implicate interactions between homologous PrP iso-forms in scrapie prion replication. Cell. 1990;63:673-686.
28.
Kretzschmar HA, Stowring LE, Westaway D., et al. Molecular cloning of a human prion protein cDNA. DNA. 1986;5:315-324.
29.
Brown P., Cervenakova L., Goldfarb LG, et al. Iatrogenic Creutzfeldt-Jakob disease: an example of the interplay
30.
between ancient genes and modern medicine. Neurology.1994;44:291-293.
31.
Hsiao K., Baker HF, Crow, TJ, et al. Linkage of the prion protein missense variant to Gerstmann-Straussler syndrome. Nature. 1989;338:342-345.
32.
Dlouhy SR, Hsiao K., Farlow MR, et al. Linkage of the Indiana kindred of Gerstmann-Straussler-Scheinker disease to the prion protein gene. Nat Genet. 1992;1:64-67.
33.
Poulter M., Baker HF, Frith CD,et al. Inherited prion disease with 144 base pair gene insertion. 1. Genealogical and molecular studies. Brain. 1992; 115:675-685.
34.
Gabizon R., Rosenmann H., Meiner Z., et al. Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease. Am J Hum Genet. 1993;33:828-835.
35.
Collinge J. , Palmer MSMolecular genetics of human prion diseases . Phil Trans R Soc Lond B.1994;343:371-378.
36.
Masters CL, Harris JO, Gajdusek DC, et al. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol.1978; 5:177-188.
37.
Prusiner SBScrapie prions. Annu Rev Microbiol.1989;43:345-374.
38.
Brown P., Cathala F., Raubertas RF, et al. The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology.1987; 37:895-904.
39.
Palmer MS, Dryden AJ, Hughes JT, Collinge J.Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature. 1991;352:340-342.
40.
Owen F., Poulter M., Collinge J., Crow TJCodon 129 changes in the prion protein gene in Caucasians. Am J Hum Genet. 1990;46:1215-1216.
41.
Gajdusek DC , Gibbs CJ Jr.Transmission of kuru from man to Rhesus monkey (Macaca mulatta) eight and one-half years after inoculation. Nature. 1972;240:351.
42.
Brown P., Cathala F., Castaigne P., et al. Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol.1986;20:597-602.
43.
Malmgren R., Kurland L., Mokri B., et al. The epidemiology of Creutzfeldt-Jakob disease. In: Prusiner SB, Hadlow WJ, eds. Slow Transmissible Diseases of the Nervous System. New York: Academic Press; 1979:93-115.
44.
Roos R., Gajdusek DC, Biggs CJThe clinical characteristics of Creutzfeldt-Jakob disease. Brain.1973;96:1-20.
45.
Galves, Masters C, Gajdusek C.Descriptive epidemiology of Creutzfeldt-Jakob disease in Chile. Arch Neurol.1980;37:11-14.
46.
Rappaport EB , Graham DJPituitary growth hormone from human cadavers: Neurologic disease in 10 recipients. Neurology. 1987;37:1211-1213.
47.
Leads from the MMWR: Creutzfeldt-Jakob disease in a second patient who received a cadaveric dura mater graft. JAMA.1989;261:1118.
48.
Thadani V., Penar PL, Partington J., et al. Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. J Neurosurg. 1988;69:766-769.
49.
Duffy P., Wolf J., Collins G., et al. Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med.1974;290:692-693.
50.
Kimberlin RH , Walker CAPathogenesis of mouse scrapie: evidence for neural spread of infection to the CNS. J Gen Virol. 1980;51:183-187.
51.
Brown P., Hooks J., Roos R., et al. Attempt to identify the agent of Creutzfeldt-Jakob disease by antibody relationship to known viruses. Nature—New Biology . 1972;235:149-152.
52.
Alpers MPEpidemiology and ecology of kuru. In: Prusiner SB, Hadlow WJ, eds. Slow Transmissible Diseases of the Nervous System. Vol.1. New York: Academic Press; 1979:67-90.
53.
Gajdusek DC , Gibbs CJ Jr., Asher DM, et al. Precautions in medical care of, and in handling materials from, patients with transmissible virus dementia (Creutzfeldt-Jakob disease). N Engl J Med.1977;297:1253-1258.
54.
McKinley MP , Hay B., Lingappa V.R., et al. Developmental expression of prion protein gene in the brain. Dev Biol. 1987;121:105-110.
55.
Beck E., Daniel PMKuru and Creutzfeldt-Jakob disease; neuropathological lesions and their significance . In: Prusiner SB, Hadlow WJ, eds. Slow Transmissible Diseases of the Nervous System. Vol. 1. New York: Academic Press; 1979:253-270.
56.
Masters CL, Richardson EPJr.Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease): the nature and progression of spongiform change. Brain. 1978;101:333-344.
57.
Gibbs CJ Jr, Gajdusek DC, Asher DM, et al. Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science. 1968;161:388-389.
58.
Gajdusek DC , Zigas V.Kuru. Am J Med.1959;26:442-469.
59.
Bastian FOCreutzfeldt-Jakob disease and other transmissible spongiform encephalopathies . St. Louis: Mosby; 1991.
60.
Collinge J. , Owen F., Poulter M., et al. Prion dementia without characteristic pathology. Lancet. 1990;336:7-9.
61.
Horopian DS , Powers JM, Schaumburg HHKuru-like neuropathological changes in a North American. Arch Neurol.1972;27:555-561.
62.
Kitamoto T. , Tateishi J., Tashima J., et al. Amyloid plaques of Creutzfeldt-Jakob disease stain with prion protein antibodies. Ann Neurol.1986;20:204-208.
63.
Roberts GW, Lofthouse R., Brown R., et al. Prion-protein immunoreactivity in human transmissible dementias . N Engl J Med.1986;315:1231-1233.
64.
Roberts GW, Lofthouse R., Allsop D., et al. CNS amyloid proteins in neurodegenerative diseases. Neurology. 1988; 38:1534-1540.
65.
Bockman JM, Kingsbury DT, McKinley MP, et al. Creutzfeldt-Jakob disease prion proteins in human brains. N Engl J Med.1985;312:73-78.
66.
Bockman JM, Prusiner SB, Tateishi J., Kingsbury DTImmunoblotting of Creutzfeldt-Jakob disease prion proteins: host species-specific epitopes. Ann Neurol.1987 ;21 ;589-595.
67.
Gajdusek DC , Zigas V.Degenerative disease of the central nervous system in New Guinea: the endemic occurrence of "kuru" in the native population . N Engl J Med.1957;257:974-978.
68.
Gomori AJ, Partnow MJ, Horoupian DS, Hirano A.The ataxic form of Creutzfeldt-Jakob disease. Arch Neurol.1973;29:318-323.
69.
Medori R., Montagna P., Tritschler HJ, et al. Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178. Neurology. 1992 ;42:669-670.
70.
Brown P., Gibbs CJ Jr, Rodgers-Johnson P., et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disese. Ann Neurol.1994;35:513-529.
71.
Olson JEBrain and CSF proteins in Creutzfeldt-Jakob disease. Eur Neurol.1980;18:85-90.
72.
Hayashi R., Hanyu N., Kuwabara T., Moriyama S.Serial computed tomographic and electroencephalographic studies in Creutzfeldt-Jakob disease. Acta Neurol Scand.1992;85:161-165.
73.
Chiappa KH, Burke CJ, Young RREarly evolution and incidence of electroencephalographic abnormalities in Creutzfeldt-Jakob disease. J Clin Neurophysiol.1986;3:1-21.
74.
Kovanen J., Erkinjunti T., Iivananinen M., et al. Cerebral MRI and CT imaging in Creutzfeldt-Jakob disease. J Comput Assist Tomogr.1985;9:125-128.
75.
Harrington MG, Merril CR, Asher DM, et al. Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. N Engl J Med.1986;315:279-283.
76.
Serban D., Taraboulos A., DeArmond SJ, Prusiner SBRapid diagnosis of Creutzfeldt-Jakob disease and scrapie prion proteins. Neurology. 1990;40: 110-117.
77.
Monari L., Chen SG, Brown P., et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci USA. 1994;91;2839-2842.
78.
Xi YG, Cardone F., Pocchiari M.Detection of proteinase-resistant protein (PrP) in small brain tissue samples from Creutzfeldt-Jakob disease patients. J Neurol Sci.1994;124:171-173.
79.
Castellani R., Parchi P., Stahl J., et al. Early pathologic and biochemical changes in Creutzfeldt-Jakob disease: study of brain biopsies. Neurology . 1996;46:1690-1693.
80.
Prusiner SB , Hsiao KKHuman prion diseases. Ann Neurol.1994;35:385-395.
81.
Furlow TW, Whitley RJ, Wilmes F.Repeated suppression of Creutzfeldt-Jakob disease with vidarabine. Lancet. 1982;2:564-565.
82.
Kovanen H., Haltia M., Cantell K.Failure of interferon to modify Creutzfeldt-Jakob disease. Br Med J.1980;280:902.
83.
Rosenberg RN , White CL III, Brown P., et al. Precautions in handling tissues, fluids, and other contaminated materials from patients with documented or suspected Creutzfeldt-Jakob disease. Ann Neurol.1986 ;19:75-77.
84.
Bastigan FO , Jennings RACreutzfeldt-Jakob disease: procedures for handling diagnostic and research materials. Infect Control.1984;5:48-50.
85.
Chatiguy MA , Prusiner SBBiohazards of investigations on the transmissible spongiform encephalopathies. Rev Infect Dis.1980;2:713-724.
86.
Taylor DMScrapie agent decontamination: implications for bovine spongiform encephalopathy . Vet Rec. 1989;124:291-292.
87.
Goldfarb LG , Brown P., Mitrova E., et al. Creutzfeldt-Jakob disease associated with the PRNP codon 2001ys mutation: an analysis of 45 families. Eur J Epidemiol.1991;7:477-486.
88.
Bruce M., Chree A., McConnell I., et al. Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Phil Trans R Soc Lond [B Biol Sci]1994;342:405-411.
89.
Collinge J. , Palmer MS, Sidle Kcl, et al. Unaltered susceptibility to BSE in transgenic mice expressing human prion protein. Nature. 1995 ;378:779-783.